Viking Global Investors discloses 15% stake in Standard Biotools
Viking Global Investors LP and affiliated entities disclosed beneficial ownership of 58,651,170 shares, or 15% of Standard Biotools Inc., in a Schedule 13D filing. The disclosure follows Viking's entry into a voting agreement on June 6, 2026, in connection with Standard Biotools' planned merger with Treeline Biosciences. Under the voting agreement, Viking committed to vote its shares in favor of merger-related proposals and against competing transactions, subject to a covered shares cap of 58,651,170 shares.
Key facts
- Viking Global Investors LP and affiliates beneficially own 58,651,170 shares (15% of class)
- Voting agreement entered June 6, 2026, in connection with Standard Biotools–Treeline Biosciences merger
- Viking committed to vote in favor of merger approval, name change to 'Treeline Biosciences Holdings, Inc.', reverse stock split, and equity plans
- Viking committed to vote against competing acquisitions and actions that would prevent or materially delay merger consummation
- Covered shares cap: 58,651,170 shares
- Reporting persons include Ole Andreas Halvorsen and Shabet Rose Sharon as individuals
- Shares acquired for investment purposes in ordinary course of business
- 10-day cooling-off period under Rule 13d-1(e)(2) applies from filing date
Why it matters
Viking's 15% stake and voting agreement give the firm significant influence over Standard Biotools' merger with Treeline, locking its shares behind transfer restrictions and commitment to support deal approval through shareholder voting.
Share
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from SCHEDULE 13D filed 2026-06-12. Not investment advice. View the source filing on SEC.gov →